SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031284
Filing Date
2023-11-09
Accepted
2023-11-09 16:25:42
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eton20230930_10q.htm   iXBRL 10-Q 867084
2 EXHIBIT 31.1 ex_561510.htm EX-31.1 8799
3 EXHIBIT 31.2 ex_561511.htm EX-31.2 8799
4 EXHIBIT 32.1 ex_561512.htm EX-32.1 6497
  Complete submission text file 0001437749-23-031284.txt   5357951

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eton-20230930.xsd EX-101.SCH 52893
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eton-20230930_cal.xml EX-101.CAL 36206
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20230930_def.xml EX-101.DEF 416095
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20230930_lab.xml EX-101.LAB 368337
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20230930_pre.xml EX-101.PRE 437124
54 EXTRACTED XBRL INSTANCE DOCUMENT eton20230930_10q_htm.xml XML 631760
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 231392963
SIC: 2834 Pharmaceutical Preparations